Simone rota

[Giuseppe Procopio @g_procopio_]

🔬 New evidence in #mHSPC
PSA nadir ≤0.2 ng/mL was strongly associated with better outcomes:
📈 OS: 92.8 vs 34 mo (HR 0.27)
📈 PFS: NR vs 12.1 mo (HR 0.19) Supporting PSA nadir as an early prognostic marker. #ProstateCancer #GUOncology
Full Article: https://t.co/3KgAAaukPr

[Giuseppe Procopio @g_procopio_]

New data in @ESMO_Open : among 59 centrally reviewed collecting duct carcinoma cases, Trop-2 was expressed in 89% and Nectin-4 in 41%, supporting further investigation of antibody-drug conjugates in this rare disease.

https://t.co/wuuASnfr0b

#KidneyCancer #RareCancer

[Giuseppe Procopio @g_procopio_]

Does local treatment of the primary tumour still add value in #mHSPC patients receiving ARPIs? Our latest expert opinion examines the evidence, ongoing controversies and future directions in the intensification era.

Article here: https://t.co/J1UAPcx9dI

#Genitourinary #Prostate

[Meet-URO @meeturoIT]

GENIE STUDY - Journal of Geriatric Oncology.
How Large langue model performs in detecting drug interaction against UpToDate?

@Simorota6, @elegusma, @g_procopio_ @elena_verzoni, @PaoloZucali, Daniele Santini

https://t.co/WIthfPdUfM

[Giuseppe Procopio @g_procopio_]

Case report: aorto-esophageal fistula after thoracic #Radiotherapy + anti-VEGF TKI in a long-survivor with #mRCC. Highlights the need for awareness of rare but severe toxicities and multidisciplinary care.
More info here: https://t.co/iquGsHlgt9
#Oncology #Genitourinary

[Federico Nichetti @fedenichetti]

@Nature_NPJ A huge thanks to @StefanFrohling @Simorota6 @am0ck @Mom_enji @PruneriG @NCT_HD @DKFZ @IstTumori @iov_irccs @oncodaily @OncoAlert

[Alessandro Rametta @alerametta]

How do we actually treat non–clear cell RCC today?

Our practical overview of systemic therapies across rare renal cancer histologies.

https://t.co/aITNVUFrCF

@g_procopio_ @elena_verzoni @marcos130990 @MelClaps @valentina79g @nzzmda @Simorota6 @elegusma

[Meet-URO @meeturoIT]

@Simorota6 Illustra l’abstract del progetto Meeturo 5/25 - GENIE ad #AIOM2025.

[Meet-URO @meeturoIT]

Meeturo Young at #Aiom2025

@AAValsecchi @Simorota6 @dici_mattia

[Meet-URO @meeturoIT]

Alcuni poster Meeturo ad #AIOM2025
@RebuzziSara @Simorota6

[Meet-URO @meeturoIT]

🔵 Grazie a tutti i partecipanti della #MeetUroAcademy 2025!
Si è concluso il primo di tre moduli dell'anno, dedicato a oncogeriatria e intelligenza artificiale in uro-oncologia.
Il percorso continua! Ci vediamo ai prossimi appuntamenti, 08-09 maggio e 20-21 novembre!

[Simone rota @Simorota6]

Session on prostate cancer led by Dr. Verzoni from INT (Istituto Nazionale dei Tumori Di Milano) and moderated by Dr. Procopio

@elena_verzoni @g_procopio_ @ACCMEDorg @IstTumori

[Simone rota @Simorota6]

Scientific Committee #grandangolo2024

@g_procopio_ @ACCMEDorg @IstTumori

[Simone rota @Simorota6]

Ready to kick off Grandangolo 2024 with the opening session on genitourinary tumors, a key opportunity for discussion and updates on critical clinical and scientific topics.

@g_procopio_ @elena_verzoni @ACCMEDorg @IstTumori @AIOMtweet @meeturoIT @elegusma

[Simone rota @Simorota6]

@_TommasoP yesssssssss e' da un po' che ce l'ho ahahaha ci sta!!

[Simone rota @Simorota6]

@MagniMattia e poi bo.... Stai studiando e le orecchie ti rimbombano per i fottutissimi fuochi ahahahah;)